The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 29 | — | 20.1x | Below average | |
Growth | 46 | 93.1% | 5.6% | Near average | |
Quality | 29 | -10.5% | 7.6% | Below average | |
Safety | 82 | — | 0.4x | Above average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | 23 | — | — | Below average | |
Sentiment | 23 | — | — | Below average |
Health In Tech, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Health In Tech, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Coverage of HIT stock saw a decrease in the number of analysts from two to one over the past 30 days, resulting in zero dispersion in the target price, which settled at $4. Although this target reflects significant optimism compared to the current price ($1.07), the exit of one analyst reduces the reliability of the general consensus and increases the state of uncertainty surrounding the stock.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.